Money AstraZeneca forecasts profit rise Aya El Sayed Feb 8, 2024 0 AstraZeneca announced on Thursday that it anticipates a rise in this year’s revenue and profit due to strong demand…
Featured France’s Sanofi to buy INBRX-101 for $2.2 bln Sama Mousa Jan 23, 2024 0 France’s Sanofi, the giant healthcare company, is set to buy US drug development project INBRX-101 from Inhibrx…
Tech/AI Sanofi coronavirus vaccine will be priced below €10 – France chief Amwal Al Ghad English Sep 6, 2020 0 A coronavirus vaccine being developed by Sanofi in partnership with Britain’s GlaxoSmithKline is expected to be…
Tech/AI Sanofi ready to produce over 600 million coronavirus vaccine doses if proven successful Amwal Al Ghad English Apr 18, 2020 0 French drugmaker Sanofi is ready to produce up to 600 million doses of its coronavirus vaccine next year if its…
Tech/AI Sanofi and GlaxoSmithKline reach unprecedented partnership to develop coronavirus vaccine Amwal Al Ghad English Apr 15, 2020 0 The European pharmaceutical giants, GlaxoSmithKline and Sanofi have entered on Tuesday an unprecedented partnership…
Life Style Scientists found new antibody that attacks 99% of HIV strains Yomna Yasser Sep 24, 2017 0 Scientists have recently engineered a new antibody that attacks 99 percent of HIV strains and can prevent infection…
Industry & Trade Sanofi, Innate Pharma say to develop tumor treatment Yomna Yasser Jan 11, 2016 0 French pharmaceutical giant Sanofi S.A.(SAN.FR) announced Monday that it sealed an agreement with Innate Pharma…
Industry & Trade AstraZeneca sells rare cancer drug to Sanofi for up to $300mn Yomna Yasser Jul 27, 2015 0 AstraZeneca (AZN.L), under pressure from falling sales of older drugs, is selling a medicine for a rare type of…
International News Sanofi wins Approval for New Insulin Drug Yomna Yasser Feb 26, 2015 0 Sanofi SA said late Wednesday it got a green light from U.S. regulators to sell its new insulin product Toujeo, a…
Industry & Trade Sanofi Cuts Forecast as Earnings Miss on Generic Woes Yomna Yasser Aug 1, 2013 0 Sanofi cut its full-year forecast as second-quarter profit missed analysts’ estimates, hurt by inventory…